Crossmark

miR-199a-5p inhibits malignant progression and enhances cisplatin sensitivity of nasopharyngeal carcinoma by targeting SLC1A5

Crossref DOI link: https://doi.org/10.1016/j.bjorl.2025.101739

Published Print: 2026-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Sun, Anchi

Lv, Rongrong

Xing, Zhiwei

He, Yifan

Wang, Xiaomin

Li, Hui https://orcid.org/0009-0009-0637-4437
Shao, Qianqian https://orcid.org/0009-0008-5294-0906
Funding

Funding for this research was provided by:

Bengbu Medical University (Byycx23029)

University Natural Science Research Project of Anhui Province (2023AH051976)
License Information

Text and Data Mining valid from 2026-03-01

Text and Data Mining valid from 2026-03-01

Version of Record valid from 2025-11-11
More Information

This article is maintained by: Elsevier

Article Title: miR-199a-5p inhibits malignant progression and enhances cisplatin sensitivity of nasopharyngeal carcinoma by targeting SLC1A5

Journal Title: Brazilian Journal of Otorhinolaryngology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.bjorl.2025.101739

Content Type: article

Copyright: © 2025 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Published by Elsevier España, S.L.U.